(jnj)

Welcome to the '(jnj)' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with '(jnj)'.

Are you an expert about '(jnj)'? Do you want to be the Technorati authority on '(jnj)'? You can write a description that will appear right here: Join Blogcritics!

Latest blogosphere posts tagged “(jnj)”

 

• UPDATE: Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharma For $650M; Includes Contingent for Possible Additional Payments of up to $350M

  
  — Authority:
  Johnson & Johnson (NYSE: JNJ ) announced today a definitive agreement to acquire Aragon Pharmaceuticals, Inc., a privately-held, pharmaceutical discovery and development company focused on drugs to treat hormonally-driven cancers. The acquisition includes Aragons androgen receptor antagonist program.
  1 day ago

• Lower Entry Prices Mean Locking Higher Yields Today

  
  Dividend Growth Investor — Authority: 573
  The beauty of dividend investing is that once an investor purchases a quality income stock, they can hold on to it for many decades, while patiently collecting cash dividends . The success of a dividend growth investor depends not only on picking the best companies in the world, but also purchasing them at the right ...
  2 days ago

• Gloomy Prospects For Medical Device Companies

  
  — Authority:
  By Ron Sommer : The medical device industry confronts several challenges that will have long-term implications. Revenue in this industry will not grow as quickly over the next five years and the increasingly strict regulatory environment will remain a significant impediment. The U.S. Food and Drug Administration ...
  2 days ago

• Johnson & Johnson Sells Remaining Stake in Elan (JNJ)

  
  Dividend Stocks - The Dividend Daily — Authority: 139
  Healthcare product company, Johnson & Johnson ( JNJ ) reported on Friday that it has sold 25.4 million shares of Elan Corp, ending its relationship with the Ireland based company. . In 2009, JNJ took a 18% stake in the biotechnology company for $1 billion to take over its development in bapineuzumab. ...
  4 days ago

• Deutsche Bank Top Medical Device Stock Picks

  
  — Authority:
  In 2012, the S&P 500 Healthcare Equipment & Supply index was up 15.1%, while the S&P 500 was up 13.4%. However, it was in-line with the broader S&P 500 Healthcare index, which was up...
  4 days ago

• Near A 52-Week Low, Is OncoGenex Pharmaceuticals A Buy?

  
  — Authority:
  ByC.R. Jackson: Approximately 90% of cancer patients with metastatic breast, prostate, lung or colon cancers develop resistance to chemotherapy. Despite scientific advances, cancer treatment failure due to treatment resistance is a major problem in oncology. OncoGenex Pharmaceuticals Inc. ( OGXI ) has focused ...
  5 days ago

• The Case Against Buying Low And Selling High

  
  — Authority:
  author name submits: One of the most basic pieces of financial wisdom that you will ever hear is the adage to "buy low and sell high." Only an idiot would argue with that, right? Well, Ill step up to the plate and be that idiot, because I do think there is a case to be made for treating the accumulation of ...
  5 days ago

• Alkermes Changing The Standard Of Care For Schizophrenia

  
  — Authority:
  By Jason Napodano : By Jason Napodano, CFA, And John Tucker, PhD Ask a scientist or healthcare portfolio manager what the hot topics are in biotechnology today, and you will likely hear about cancer immunotherapy, stem cells, RNA interference and exon-skipping technologies. One subject they will probably not ...
  5 days ago

• Johnson & Johnson (JNJ): Is This Healthcare Company a Strong Investment?

  
  — Authority:
  The slowdown in stock market has also adversely affected leading healthcare companies’ stocks. But many still think investing in healthcare giants such as Johnson & Johnson (NYSE : JNJ ) is the right move. Let’s take a closer look at this company and break down its main strong points, opportunities, and ...
  5 days ago

• Undervalued Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Must Enter New Markets

  
  — Authority:
  Generic producers are often regarded as the safer players within BioPharma. They take existing drugs that have fallen off patents, tweak them a bit, and release a product into the market. R&D expenses are kept low, and business is relatively predictable. Similarly, medical device companies have lower risk ...
  5 days ago

• Taking The Active Versus Passive Investing Debate A Step Further

  
  — Authority:
  This is one of a series of blog posts from the Morningstar Investment Conference in Chicago.
  6 days ago

• The Cooper Companies, Inc. (COO), Valeant Pharmaceuticals Intl Inc (VRX): Tme to Buy This Defensive Growth Stock?

  
  — Authority:
  Everyone loves a defensive growth story, and there aren’t many better companies in the category than The Cooper Companies, Inc. (NYSE: COO ) . In general, ophthalmology is an industry that can grow irrespective of the economy. Within this, The Cooper Companies, Inc. (NYSE:COO) has its own mix of earnings drivers ...
  6 days ago

• Portfolio Management - 10 Tips For Better Results

  
  — Authority:
  ByRob Stein: Every portfolio has a structure. It may be a planned one with thought given to creating a diverse mix of stocks, bonds, mutual funds, and other securities; or it may be unplanned and simply grow organically in various directions depending on buys and sells over time. The more prudent course is to have a ...
  6 days ago

• Johnson & Johnson Drug Receives Positive Data in Trials (JNJ)

  
  Dividend Stocks - The Dividend Daily — Authority: 139
  According to data being presented at a medical meeting in Europe, Johnson & Johnson’s ( JNJ ) new drug to combat psoriatic arthritis, Stelara, has produced positive results in recent testing and trials. Through 52 weeks of treatment the drug has produced significant improvements in psoriatic ...
  6 days ago

• Some Top Funds Are Dumping Bonds

  
  TheStreet.com — Authority: 544
  NEW YORK (TheStreet) -- Bond funds have been struggling. The average intermediate-term fund dropped 1.9% during the past month. Rising interest rates have caused the losses. When rates climb, bond prices tend to fall. Is it time to start trimming your bond holdings? Some top-performing fund managers think so. These ...
  6 days ago

• When It Comes To Biotech, Diversity Is Key

  
  — Authority:
  ByMike Perinotti: The biotech industry has become a bit of a crap-shoot with investors left to the mercy of FDA decisions, lawsuits, and drug recalls. Nonetheless, biotech remains one of the most actively invested in sectors with the potential for big pay-offs as many biotech companies are reporting margins of 30% ...
  6 days ago

• Do Performance Comparisons To S&P 500 Matter To Dividend Growth Investors?

  
  — Authority:
  By Dividend Growth Investor : One of the questions I received recently from several readers of my site asked about my total returns performance and my benchmarks. My benchmark for my total returns and dividend income is the S&P 500. However, benchmarking my dividend income is more important to me than looking ...
  6 days ago

• Tentative Approval for SUPN Candidate – Analyst Blog

  
  — Authority:
  Supernus Pharma received tentative FDA approval for Trokendi XR
  1 week ago

• Johnson & Johnson (JNJ), The Coca-Cola Company (KO), AT&T Inc. (T): Three High Dividend Stocks to Consider at Market Dips

  
  — Authority:
  Wall Street fell recently as high-yielding dividend stocks lost their traction. This was triggered by fears raised by Federal Reserve Chairman Ben Bernanke that the Fed’s bond buying program may soon end earlier than expected. As a result, many dividend stocks fell. Not even the high profile and more stable stocks ...
  1 week ago

• UBS Top Dividend Growing Stocks to Buy for Income

  
  — Authority:
  Over the past month, interest rates have bounced off of their 2013 lows, with the U.S. 10-year yield quickly rising from 1.66% to more than 2.20%. This has been a negative for dividend-paying stocks...
  1 week ago

Comments about (jnj)